Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Diabetes, Cardiovascular Risks, and Lipoproteins, and Dementia and Cognitive Impairment Research.
Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden
Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD
From “Burnt-Out” to “Burning-Out”: Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction–Associated Steatotic Liver Disease From a Dynamic Perspective
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD
Association between longitudinal weight change and clinical outcome in individuals with MASLD
Cardiovascular–kidney–metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study
WDR62 affects the progression of ovarian cancer by regulating the cell cycle
P3.18.77 Efficacy and Safety of Adebrelimab Plus Irinotecan Liposome in ES-SCLC After First-Line Therapy: A Phase II Study (AIPATH)
IDDF2025-ABS-0058 Longitudinal changes in fibrosis markers: monitoring stiffness/fibrosis progression and prognostic outcomes in metabolic dysfunction-associated steatotic liver disease
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes
Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study
Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study
Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial
Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD
Four‐fold increased mortality rate in patients with Wilson's disease: A population‐based cohort study of 151 patients
Risk of infections in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study
Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression
Nonalcoholic Fatty Liver Disease and Risk of Dementia
Risk of cardiovascular disease and loss in life expectancy in NAFLD
The impact of diabetes on cognitive impairment and its progression to dementia
Metabolic Syndrome Is Associated With Poor Cognition: A Population-Based Study of 70-Year-Old Adults Without Dementia